143 related articles for article (PubMed ID: 28840514)
1. Gαq/p63RhoGEF interaction in RhoA/Rho kinase signaling: investigation in Gitelman's syndrome and implications with hypertension.
Pagnin E; Ravarotto V; Maiolino G; Naso E; Davis PA; Calò LA
J Endocrinol Invest; 2018 Mar; 41(3):351-356. PubMed ID: 28840514
[TBL] [Abstract][Full Text] [Related]
2. Increased level of p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients.
Calò LA; Davis PA; Pagnin E; Dal Maso L; Maiolino G; Seccia TM; Pessina AC; Rossi GP
J Hypertens; 2014 Feb; 32(2):331-8. PubMed ID: 24356540
[TBL] [Abstract][Full Text] [Related]
3. The blocking of angiotensin II type 1 receptor and RhoA/Rho kinase activity in hypertensive patients: Effect of olmesartan medoxomil and implication with cardiovascular-renal remodeling.
Ravarotto V; Pagnin E; Maiolino G; Fragasso A; Carraro G; Rossi B; Calò LA
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1245-50. PubMed ID: 26240115
[TBL] [Abstract][Full Text] [Related]
4. High angiotensin II state without cardiac remodeling (Bartter's and Gitelman's syndromes): are angiotensin II type 2 receptors involved?
Calò LA; Montisci R; Scognamiglio R; Davis PA; Pagnin E; Schiavo S; Mormino P; Semplicini A; Palatini P; D'Angelo A; Pessina AC
J Endocrinol Invest; 2009 Nov; 32(10):832-6. PubMed ID: 19605975
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic approach to the pathophysiology of target organ damage in hypertension from studies in a human model with characteristics opposite to hypertension: Bartter's and Gitelman's syndromes.
Calò LA; Maiolino G
J Endocrinol Invest; 2015 Jul; 38(7):711-6. PubMed ID: 25740064
[TBL] [Abstract][Full Text] [Related]
6. Proinflammatory/profibrotic effects of aldosterone in Gitelman's syndrome, a human model opposite to hypertension.
Ravarotto V; Simioni F; Sabbadin C; Pagnin E; Maiolino G; Armanini D; Calò LA
J Endocrinol Invest; 2019 May; 42(5):521-526. PubMed ID: 30136149
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II and Cardiovascular-Renal Remodelling in Hypertension: Insights from a Human Model Opposite to Hypertension.
Ravarotto V; Pagnin E; Fragasso A; Maiolino G; Calò LA
High Blood Press Cardiovasc Prev; 2015 Sep; 22(3):215-23. PubMed ID: 25759028
[TBL] [Abstract][Full Text] [Related]
8. Reduced mRNA and protein content of rho guanine nucleotide exchange factor (RhoGEF) in Bartter's and Gitelman's syndromes: relevance for the pathophysiology of hypertension.
Pagnin E; Semplicini A; Sartori M; Pessina AC; Calò LA
Am J Hypertens; 2005 Sep; 18(9 Pt 1):1200-5. PubMed ID: 16182110
[TBL] [Abstract][Full Text] [Related]
9. Understanding the mechanisms of angiotensin II signaling involved in hypertension and its long-term sequelae: insights from Bartter's and Gitelman's syndromes, human models of endogenous angiotensin II signaling antagonism.
Calò LA; Davis PA; Rossi GP
J Hypertens; 2014 Nov; 32(11):2109-19; discussion 2119. PubMed ID: 25202962
[TBL] [Abstract][Full Text] [Related]
10. Structure of Galphaq-p63RhoGEF-RhoA complex reveals a pathway for the activation of RhoA by GPCRs.
Lutz S; Shankaranarayanan A; Coco C; Ridilla M; Nance MR; Vettel C; Baltus D; Evelyn CR; Neubig RR; Wieland T; Tesmer JJ
Science; 2007 Dec; 318(5858):1923-7. PubMed ID: 18096806
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of Post Transplant Hypertension in Kidney Transplant: Focus on Calcineurin Inhibitors Induced Oxidative Stress and Renal Sodium Retention and Implications with RhoA/Rho Kinase Pathway.
Calò LA; Ravarotto V; Simioni F; Naso E; Marchini F; Bonfante L; Furian L; Rigotti P
Kidney Blood Press Res; 2017; 42(4):676-685. PubMed ID: 29131070
[TBL] [Abstract][Full Text] [Related]
12. p63RhoGEF regulates auto- and paracrine signaling in cardiac fibroblasts.
Ongherth A; Pasch S; Wuertz CM; Nowak K; Kittana N; Weis CA; Jatho A; Vettel C; Tiburcy M; Toischer K; Hasenfuss G; Zimmermann WH; Wieland T; Lutz S
J Mol Cell Cardiol; 2015 Nov; 88():39-54. PubMed ID: 26392029
[TBL] [Abstract][Full Text] [Related]
13. Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter's/Gitelman's syndromes.
Calò LA; Pagnin E; Ceolotto G; Davis PA; Schiavo S; Papparella I; Semplicini A; Pessina AC
J Hypertens; 2008 May; 26(5):938-45. PubMed ID: 18398336
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II activates the RhoA exchange factor Arhgef1 in humans.
Carbone ML; Brégeon J; Devos N; Chadeuf G; Blanchard A; Azizi M; Pacaud P; Jeunemaître X; Loirand G
Hypertension; 2015 Jun; 65(6):1273-8. PubMed ID: 25870189
[TBL] [Abstract][Full Text] [Related]
15. Absence of vascular remodelling in a high angiotensin-II state (Bartter's and Gitelman's syndromes): implications for angiotensin II signalling pathways.
Calò LA; Puato M; Schiavo S; Zanardo M; Tirrito C; Pagnin E; Balbi G; Davis PA; Palatini P; Pauletto P
Nephrol Dial Transplant; 2008 Sep; 23(9):2804-9. PubMed ID: 18344243
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of recruitment and allosteric activation of ARHGEF25 isoforms by the heterotrimeric G-protein Gαq.
van Unen J; Yin T; Wu YI; Mastop M; Gadella TW; Goedhart J
Sci Rep; 2016 Nov; 6():36825. PubMed ID: 27833100
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of Gαq-protein-p63RhoGEF interaction and its regulation by RGS2.
Bodmann EL; Rinne A; Brandt D; Lutz S; Wieland T; Grosse R; Bünemann M
Biochem J; 2014 Feb; 458(1):131-40. PubMed ID: 24299002
[TBL] [Abstract][Full Text] [Related]
19. Human p63RhoGEF, a novel RhoA-specific guanine nucleotide exchange factor, is localized in cardiac sarcomere.
Souchet M; Portales-Casamar E; Mazurais D; Schmidt S; Léger I; Javré JL; Robert P; Berrebi-Bertrand I; Bril A; Gout B; Debant A; Calmels TP
J Cell Sci; 2002 Feb; 115(Pt 3):629-40. PubMed ID: 11861769
[TBL] [Abstract][Full Text] [Related]
20. The RhoA-specific guanine nucleotide exchange factor p63RhoGEF binds to activated Galpha(16) and inhibits the canonical phospholipase Cbeta pathway.
Yeung WW; Wong YH
Cell Signal; 2009 Aug; 21(8):1317-25. PubMed ID: 19332116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
